Simcere Pharmaceutical Group Limited (2096.HK)

HKD 8.74

(2.1%)

Operating Expenses Summary of Simcere Pharmaceutical Group Limited

Simcere Pharmaceutical Group Limited's latest annual operating expenses in 2023 was 4.27 Billion CNY , down -3.68% from previous year.
Simcere Pharmaceutical Group Limited's latest quarterly operating expenses in 2024 Q2 was 984.88 Million CNY , down 0.0% from previous quarter.
Simcere Pharmaceutical Group Limited reported a annual operating expenses of 4.42 Billion CNY in annual operating expenses 2022, up 19.35% from previous year.
Simcere Pharmaceutical Group Limited reported a annual operating expenses of 3.7 Billion CNY in annual operating expenses 2021, up 22.69% from previous year.
Simcere Pharmaceutical Group Limited reported a quarterly operating expenses of 984.88 Million CNY for 2024 Q2, down 0.0% from previous quarter.
Simcere Pharmaceutical Group Limited reported a quarterly operating expenses of 2.01 Billion CNY for 2023 Q4, up 0.19% from previous quarter.

Annual Operating Expenses Chart of Simcere Pharmaceutical Group Limited (2023 - 2012)

Historical Annual Operating Expenses of Simcere Pharmaceutical Group Limited (2023 - 2012)

Year	Operating Expenses	Operating Expenses Growth
2023	4.27 Billion CNY	-3.68%
2022	4.42 Billion CNY	19.35%
2021	3.7 Billion CNY	22.69%
2020	3.01 Billion CNY	0.36%
2019	3 Billion CNY	3.59%
2018	2.9 Billion CNY	12.54%
2017	2.58 Billion CNY	0.0%
2012	1.67 Billion CNY	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	984.88 Million CNY	-51.04%
2024 Q2	984.88 Million CNY	0.0%
2023 Q4	2.01 Billion CNY	0.19%
2023 FY	4.25 Billion CNY	-3.68%
2023 Q1	124.44 Million CNY	-87.77%
2023 Q2	124.44 Million CNY	0.0%
2023 Q3	2 Billion CNY	1513.36%
2022 Q1	1.05 Billion CNY	50.8%
2022 FY	4.42 Billion CNY	19.35%
2022 Q4	1.01 Billion CNY	0.0%
2022 Q3	1.01 Billion CNY	-3.19%
2022 Q2	1.05 Billion CNY	0.0%
2021 Q3	696.78 Million CNY	24.23%
2021 FY	3.7 Billion CNY	22.69%
2021 Q1	560.9 Million CNY	-22.76%
2021 Q2	560.9 Million CNY	0.0%
2021 Q4	696.78 Million CNY	0.0%
2020 Q4	726.19 Million CNY	0.0%
2020 FY	3.01 Billion CNY	0.36%
2020 Q1	621.91 Million CNY	-20.54%
2020 Q2	621.91 Million CNY	0.0%
2020 Q3	726.19 Million CNY	16.77%
2019 Q2	709.92 Million CNY	0.0%
2019 Q1	709.92 Million CNY	0.0%
2019 Q4	782.64 Million CNY	0.0%
2019 FY	3 Billion CNY	3.59%
2019 Q3	782.64 Million CNY	10.24%
2018 FY	2.9 Billion CNY	12.54%
2017 FY	2.58 Billion CNY	0.0%
2013 Q1	379.18 Million CNY	-25.23%
2013 Q2	398.79 Million CNY	5.17%
2013 Q3	220.55 Million CNY	-44.69%
2012 Q1	-437.45 Million CNY	0.0%
2012 Q2	-494.08 Million CNY	-12.94%
2012 Q3	400.54 Million CNY	181.07%
2012 Q4	507.14 Million CNY	26.61%
2012 FY	1.67 Billion CNY	0.0%

Peer Operating Expenses Comparison of Simcere Pharmaceutical Group Limited

Name	Operating Expenses	Operating Expenses Difference
Uni-Bio Science Group Limited	325.05 Million HKD	-1214.367%
CK Life Sciences Int'l., (Holdings) Inc.	739.25 Million HKD	-477.927%